Alkermes (ALKS) Tops Q1 EPS by 5c
Tweet
Share
E-mail
Get Alerts ALKS Hot Sheet
Price: $46.10 -1.66%
EPS Growth %: -108.2%
Financial Fact:
Selling, general and administrative: 11.1M
Today's EPS Names:
VIVO, BIOX, PMCB, More
EPS Growth %: -108.2%
Financial Fact:
Selling, general and administrative: 11.1M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Alkermes (NASDAQ: ALKS) reported Q1 EPS of ($0.17), $0.05 better than the analyst estimate of ($0.22). Revenue for the quarter came in at $223.1 million versus the consensus estimate of $216.99 million.
For earnings history and earnings-related data on Alkermes (ALKS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- EU proposes to curb Airbnb and short-term rentals amid housing shortage
- Lynx Equity sees Micron and SanDisk breakout as volatility normalizes
- Bernstein SocGen Group Reiterates Outperform Rating on Zydus Lifesciences (ZYDUSLIF:IN)
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
